In lung adenocarcinoma, IGF-1R overexpression and Akt activation by NOTCH1 is stimulated by hypoxic microenvironment [38], and NOTCH1 targeting may provide a viable therapeutic approach for patients with K-Ras mutant lung adenocarcinoma [39]. The gene discussed is AKT1; the disease is lung adenocarcinoma.